Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea

Tuberculosis and Respiratory Diseases

article

Changhwan Kim¹  Younhee Kim²  Dong-Wook Yang³  Chin Kook Rhee⁴  Sung Kyoung Kim⁵  Yong-Il Hwang⁶  Yong Bum Park⁷  Young Mok Lee⁸  Seonglim Jin⁹  Jinkyeong Park^1,10  Cho-Rom Hahm^1,11  Chang-Han Park^1,12  So Yeon Park^1,13  Cheol Kweon Jung^1,14  Yu-Il Kim^1,15  Sang Haak Lee^1,16  Hyoung Kyu Yoon^1,17  Jin Hwa Lee^1,18  Seong Yong Lim^1,19  Kwang Ha Yoo^2,20 

[1] Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine;Institute of Health and Environment, School of Public Health, Seoul National University;Graduate School of Public Health, Seoul National University;Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea;Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea;Department of Internal Medicine, Hallym University Sacred Heart Hospital;Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital;GF Allergy Clinic;Beautiful Breath Clinic;Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital;Department of Internal Medicine, Gwangmyeong Sungae Hospital;Department of Internal Medicine, Sungae Hospital;A&A Clinic;Sanbon Yonsei Clinic;Department of Internal Medicine, Chonnam National University Hospital;Department of Internal Medicine, St. Paul's Hospital, College of Medicine, The Catholic University of Korea;Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea;Department of Internal Medicine, School of Medicine, Ewha Womans University;Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine;Department of Internal Medicine, Konkuk University School of Medicine

关键词: Pulmonary Disease;    Chronic Obstructive;    Health Care Costs;    Korea;   

DOI  :  10.4046/trd.2018.0035

学科分类：医学（综合）

来源: The Korean Academy of Tuberculosis and Respiratory Diseases

【 摘 要 】

Background Understanding the burden of disease is important to establish cost-effective treatment strategies and to allocate healthcare resources appropriately. However, little reliable information is available regarding the overall economic burden imposed by chronic obstructive pulmonary disease (COPD) in Korea. Methods This study is a multicenter observational research on the COPD burden in Korea. Total COPD costs were comprised of three categories: direct medical, direct non-medical, and indirect costs. For direct medical costs, institutional investigation was performed at 13 medical facilities mainly based on the claims data. For direct non-medical and indirect costs, site-based surveys were administered to the COPD patients during routine visits. Total costs were estimated using the COPD population defined in the recent report. Results The estimated total costs were approximately 1,245 million US dollar (1,408 billion Korean won). Direct medical costs comprised approximately 20% of the total estimated costs. Of these, formal medical costs held more than 80%. As direct non-medical costs, nursing costs made up the largest percentage (39%) of the total estimated costs. Costs for COPD-related loss of productivity formed four fifths of indirect costs, and accounted for up to 33% of the total costs. Conclusion This study shows for the first time the direct and indirect costs of COPD in Korea. The total costs were enormous, and the costs of nursing and lost productivity comprised approximately 70% of total costs. The results provide insight for an effective allocation of healthcare resources and to inform establishment of strategies to reduce national burden of COPD.

【 授权许可】

CC BY-NC